<DOC>
	<DOCNO>NCT02948374</DOCNO>
	<brief_summary>Critical care patient high risk develop delirium impair cognitive function 3 12 month ICU stay . In study aim try elucidate pathophysiology behind delirium ICU subsequent development cognitive dysfunction ICU survivor . Biomarkers cerebrospinal fluid ( CSF ) analyse patient without delirium ICU . Samples also take 3 12 month ICU-stay . CSF also obtain healthy age- sexmatched control undergo surgery .</brief_summary>
	<brief_title>Biomarkers Cerebrospinal Fluid Critical Care Patients With Delirium</brief_title>
	<detailed_description>Critical care patient high risk develop delirium , form acute brain dysfunction , may develop impaired cognitive function 3 12 month follow ICU stay . In study aim try elucidate pathophysiology behind delirium ICU comparing patient without delirium possible development cognitive dysfunction ICU survivor . Neuroinflammatory marker marker structural damage cerebrospinal fluid ( CSF ) analyse patient without delirium assess CAM-ICU ( Confusion Assessment Method ) test ICU . CSF sample also take ICU-survivors , 3 12 month ICU-stay . For comparison CSF obtain healthy age- sexmatched control undergo surgery spinal anesthesia .</detailed_description>
	<mesh_term>Delirium</mesh_term>
	<criteria>Patients admit ICU acute respiratory , septic and/or circulatory chock Abnormal coagulation Recent exposure intensive care Patients unable assess delirium Patients difficult follow Patients expect live less 24 hr Patients know cognitive dysfunction base medical record relatives report Abnormal coagulation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>